HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
William J Gradishar Selected Research
William J Gradishar Research Topics
Disease
102
Breast Neoplasms (Breast Cancer)
01/2022 - 01/2002
35
Neoplasms (Cancer)
01/2022 - 04/2003
7
Triple Negative Breast Neoplasms
01/2021 - 07/2015
7
Neutropenia
01/2013 - 06/2005
6
Disease Progression
04/2021 - 06/2006
4
Circulating Neoplastic Cells
06/2021 - 05/2014
4
Neoplasm Metastasis (Metastasis)
07/2017 - 10/2012
3
Fatigue
09/2018 - 08/2009
2
Hematologic Neoplasms (Hematological Malignancy)
10/2018 - 01/2009
2
Leukemia
10/2018 - 04/2003
2
Cardiotoxicity
10/2018 - 04/2003
2
Anemia
09/2018 - 01/2005
2
Thrombocytopenia (Thrombopenia)
09/2018 - 01/2009
2
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2014 - 01/2009
2
Febrile Neutropenia
10/2012 - 08/2009
2
Hypersensitivity (Allergy)
06/2006 - 11/2005
1
Ductal Carcinoma
01/2022
1
Lobular Carcinoma
01/2022
1
Neoplasm Micrometastasis
12/2021
1
COVID-19
06/2020
1
Brain Neoplasms (Brain Tumor)
09/2019
1
Hyperglycemia
09/2018
1
Exanthema (Rash)
09/2018
1
Inflammation (Inflammations)
12/2017
1
Hypertension (High Blood Pressure)
12/2017
1
Diarrhea
12/2017
1
Inflammatory Breast Neoplasms
02/2017
Drug/Important Bio-Agent (IBA)
29
Hormones (Hormone)
IBA
01/2022 - 04/2003
11
Estrogen Receptors
IBA
12/2021 - 08/2003
10
Aromatase Inhibitors
IBA
01/2021 - 05/2003
10
Tamoxifen
FDA Link
Generic
01/2017 - 01/2002
10
Paclitaxel (Taxol)
FDA Link
Generic
04/2013 - 04/2003
9
Trastuzumab (Herceptin)
FDA Link
01/2022 - 08/2003
9
taxane
IBA
10/2018 - 05/2004
7
Capecitabine (Xeloda)
FDA Link
11/2021 - 04/2003
7
Docetaxel (Taxotere)
FDA Link
04/2013 - 04/2003
7
Doxorubicin (Adriamycin)
FDA Link
Generic
01/2009 - 04/2003
6
Biomarkers (Surrogate Marker)
IBA
11/2021 - 10/2008
6
human ERBB2 protein
IBA
01/2021 - 01/2013
5
Circulating Tumor DNA
IBA
01/2022 - 01/2018
5
ErbB Receptors (EGF Receptor)
IBA
12/2021 - 01/2016
5
Cyclophosphamide (Cytoxan)
FDA Link
Generic
10/2018 - 04/2003
5
Anthracyclines
IBA
10/2018 - 04/2003
5
130-nm albumin-bound paclitaxel
IBA
04/2013 - 06/2006
4
Progesterone Receptors (Progesterone Receptor)
IBA
12/2021 - 10/2008
4
exemestane (Aromasin)
FDA Link
01/2019 - 05/2003
4
Sorafenib (BAY 43-9006)
FDA Link
12/2017 - 08/2012
4
Pharmaceutical Preparations
IBA
02/2017 - 12/2007
4
Albumin-Bound Paclitaxel
FDA Link
04/2013 - 11/2005
4
Solvents
IBA
08/2009 - 11/2005
4
Taxoids (Taxanes)
IBA
06/2006 - 01/2003
4
Anastrozole (Arimidex)
FDA Link
Generic
01/2005 - 04/2003
3
Proteins (Proteins, Gene)
FDA Link
01/2022 - 10/2008
3
Lapatinib (GW572016)
FDA Link
11/2021 - 10/2018
3
Fulvestrant (Faslodex)
FDA Link
01/2019 - 04/2005
3
Estrogens (Estrogen)
FDA Link
12/2017 - 07/2015
2
Letrozole (Femara)
FDA Link
Generic
04/2021 - 05/2003
2
Everolimus
FDA Link
01/2018 - 05/2014
2
TOR Serine-Threonine Kinases
IBA
01/2018 - 01/2016
2
Estrogen Receptor Modulators (Antiestrogen)
IBA
01/2016 - 04/2005
2
Epidermal Growth Factor (EGF)
IBA
07/2015 - 10/2008
2
Albumins
IBA
10/2008 - 06/2006
2
Selective Estrogen Receptor Modulators (SERM)
IBA
06/2006 - 01/2005
2
Matrix Metalloproteinase Inhibitors
IBA
02/2006 - 12/2004
2
marimastat
IBA
02/2006 - 12/2004
2
Fluorouracil (Carac)
FDA Link
Generic
07/2003 - 04/2003
1
neratinib
IBA
11/2021
1
Estradiol (Delestrogen)
FDA Link
Generic
04/2021
1
margetuximab
IBA
04/2021
1
DNA (Deoxyribonucleic Acid)
IBA
08/2020
1
Indicators and Reagents (Reagents)
IBA
01/2019
1
thymidine kinase 1
IBA
01/2019
1
Levonorgestrel (Plan B)
FDA Link
Generic
10/2018
1
Alpelisib
IBA
09/2018
1
Ado-Trastuzumab Emtansine
IBA
09/2018
1
Enzymes
IBA
09/2018
1
tremelimumab
IBA
04/2018
1
durvalumab
IBA
04/2018
1
Immune Checkpoint Inhibitors
IBA
04/2018
1
Cell-Free Nucleic Acids
IBA
01/2018
1
Zoledronic Acid (Zometa)
FDA Link
07/2017
1
Pamidronate (Aredia)
FDA Link
Generic
07/2017
1
Diphosphonates (Bisphosphonates)
IBA
07/2017
1
Messenger RNA (mRNA)
IBA
01/2016
1
Insulin Receptor
IBA
01/2016
1
Somatomedin Receptors (Somatomedin Receptor)
IBA
01/2016
Therapy/Procedure
66
Therapeutics
01/2022 - 01/2002
29
Drug Therapy (Chemotherapy)
01/2022 - 04/2003
10
Adjuvant Chemotherapy
01/2022 - 01/2003
6
Radiotherapy
01/2017 - 01/2008
3
Neoadjuvant Therapy
05/2020 - 05/2004
3
Biological Therapy
03/2016 - 04/2014
2
Precision Medicine
08/2020 - 07/2012
2
Stem Cell Transplantation
01/2009 - 07/2003
2
Combination Drug Therapy (Combination Chemotherapy)
09/2007 - 04/2003
2
Premedication
06/2006 - 11/2005
1
Segmental Mastectomy (Lumpectomy)
10/2021
1
Lymph Node Excision (Lymph Node Dissection)
02/2021
1
Mastectomy (Mammectomy)
02/2021
1
Ambulatory Care (Outpatient Care)
06/2020